Effect of finerenone on urinary protein and inflammatory factor levels in type 2 diabetes mellitus patients with diabetic kidney disease.
<h4>Aims</h4>This study aimed to investigate the efficacy and safety of finerenone in the treatment of diabetic kidney disease (DKD) in the real-world medical setting and explore the underlying mechanism of its kidney-protecting effects from the perspective of the inflammatory response.&...
Saved in:
| Main Authors: | Jia Song, Yan Kang, LiNa Wang, YuQing Guo, XinJu Jia, ShanShan Dong, YiMeng Li, Dan Wang, JingMin Gao, AiGe Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0329965 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A new era of cardiac nephroprotection in patients with type 2 diabetes mellitus: the role of Finerenone
by: I. S. Khalimov, et al.
Published: (2025-01-01) -
Efficacy and safety of finerenone in individuals with type 2 diabetes mellitus complicated by diabetic kidney disease: A retrospective observational study
by: Yuji Kawaguchi, et al.
Published: (2024-12-01) -
Urinary Angiopoietin-2 Is Associated with Albuminuria in Patients with Type 2 Diabetes Mellitus
by: Shan Chen, et al.
Published: (2015-01-01) -
Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD
by: Masayuki Yamanouchi, et al.
Published: (2025-07-01) -
A meta-analysis of the effects of finerenone on cardio-renal outcomes in patients with type 2 diabetes mellitus or chronic kidney disease
by: Liu Jing, et al.
Published: (2025-06-01)